AbbVie pays $700M upfront for trispecific rival to J&J, Pfizer in blood cancer

fiercebiotech.com/biotech/abbvie-pays-700m-upfront-trispecific-rival-jj-pfizer-blood-cancer

This story appeared on fiercebiotech.com, 2025-07-11 08:57:56.997000.
The Entire Business World on a Single Page. Free to Use →